Innoviva (INVA) Debt Ratio (2010 - 2026)
Innoviva (INVA) posted Debt Ratio of 0.14 for Q1 2026, down 10.84% on a QoQ basis from 0.16 in Q4 2025, and down 60.73% year-over-year from 0.36 in Q1 2025.
Innoviva (INVA) Debt Ratio (2010 - 2026) Analysis & Trends
Innoviva's Debt Ratio history runs 17 years deep, the most recent figure standing at 0.14 for Q1 2026.
- Quarterly Debt Ratio fell 60.73% year-over-year to 0.14 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.14 (down 60.73% YoY) and the FY2025 annual result came in at 0.16, down 54.26% from the prior year.
- Debt Ratio was 0.14 for Q1 2026 at Innoviva, down from 0.16 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.44 in Q4 2022 and bottomed at 0.08 in Q2 2022.
- A 5-year average of 0.3 and a median of 0.36 in 2025 frame the typical range for Debt Ratio.
- Annual changes were most pronounced in 2022 — Debt Ratio tumbled 82.91% — and 2023, when it jumped 371.44%.
- Innoviva's Debt Ratio stood at 0.44 in 2022, then dropped by 18.22% to 0.36 in 2023, then retreated by 3.97% to 0.34 in 2024, then sank by 54.26% to 0.16 in 2025, then decreased by 10.84% to 0.14 in 2026.
- Business Quant data shows INVA's Debt Ratio at 0.14 in Q1 2026, 0.16 in Q4 2025, and 0.18 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 1.41 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.11 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.05 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Innoviva | 1.57 Bn | 969.11 Mn | 75.83 Mn | 0.14 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.14 |
| Dec 31, 2025 | 0.16 |
| Sep 30, 2025 | 0.18 |
| Jun 30, 2025 | 0.34 |
| Mar 31, 2025 | 0.36 |
| Dec 31, 2024 | 0.34 |
| Sep 30, 2024 | 0.36 |
| Jun 30, 2024 | 0.37 |
| Mar 31, 2024 | 0.35 |
| Dec 31, 2023 | 0.36 |
| Sep 30, 2023 | 0.38 |
| Jun 30, 2023 | 0.40 |
| Mar 31, 2023 | 0.39 |
| Dec 31, 2022 | 0.44 |
| Sep 30, 2022 | 0.41 |
| Jun 30, 2022 | 0.08 |
| Mar 31, 2022 | 0.09 |
| Dec 31, 2021 | 0.43 |
| Sep 30, 2021 | 0.44 |
| Jun 30, 2021 | 0.49 |